{"nct_id":"NCT05207722","title":"CYNK-101 in Combination with Trastuzumab and Pembrolizumab in Patients with Locally Advanced Unresectable or Metastatic HER2-Positive Gastric or Gastroesophageal Junction (G/GEJ) Adenocarcinoma","status":"TERMINATED","status_verified_date":"2024-02","start_date":"2022-04-14","start_date_type":"ACTUAL","primary_completion_date":"2024-02-15","primary_completion_date_type":"ACTUAL","completion_date":"2024-02-15","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["CELU"]}